AHCO - AdaptHealth Corp.
AdaptHealth (NASDAQ: AHCO - Get Free Report) and Precipio (NASDAQ: PRPO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of current ratings
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences: The 2026 Jefferies Healthcare Services and Technology Conference, being held in Nashville, on Monday, September 14, 2026, including a.
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that its Board of Directors has named Harriss T. Currie as its Chief Financial Officer, effective September 9, 2026. Mr. Currie will assume CFO responsibilities from Jason Clemens, who will assist with the transition through.
AdaptHealth Corp. (NASDAQ: AHCO) (âAdaptHealthâ or the âCompanyâ), a national leader in providing patient-centered, healthcare-at-home solutions includi
New platform brings four of the industry's most recognized direct-to-consumer brands together to serve the cash-pay obstructive sleep apnea (OSA) market across North America NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Cathay Capital today announced the launch of ReDream Brands , a new consumer sleep health platform dedicated to helping millions of people achieve better sleep and healthier lives. The platform brings together four of the industry's most recognized direct-to-consumer brands: cpap.com, The CPAP Shop, Lofta and sleeping.com, creating a leading platform for cash-pay OSA customers across North America.
CONSHOHOCKEN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the AdaptHealth Corp. (Nasdaq: AHCO) data breach.
AdaptHealth Corp. reported second quarter 2026 revenue of $740.3 million against consensus of roughly $847 million to $849 million, and a GAAP loss of $0.99 per share against expectations of approximately $0.15. Shares fell as much as 26%.
AdaptHealth NASDAQ: AHCO executives outlined the company's second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion.
AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The company also lowered its fiscal performance targets for the year.
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv
LOS ANGELES--(BUSINESS WIRE)---- $AHCO--AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Canaccord Genuity 46th Annual Growth Conference, being held in Boston, on Tuesday, August 11, 2026, including a fireside chat from 9:00 – 9:25 a.m. E.
NEW YORK--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) shares fell as much as 26% after the Company reported second quarter revenue of $740.3 million, well below approximately $847 million expected, a GAAP loss driven in part by a $144.2 million goodwill impairment charge, and a substantial reduction to full-year guidance. If you suffered a loss on your AdaptHealth investment, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email a.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ADAPTHEALTH CORP. (AHCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? O.
Law Offices of Howard G. Smith announces an investigation on behalf of AdaptHealth Corp. (âAdaptHealthâ or the âCompanyâ) (NASDAQ: [url="]AHCO[/url]) in
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ADAPTHEALTH CORP. (AHCO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by e.
AdaptHealth (NASDAQ: AHCO) reported second-quarter revenue growth in its continuing operations but lowered its full-year profitability outlook, citing higher-than-expected costs in its West Coast capitated contract, a supplier price increase and portfolio actions. Chief Executive Officer Suzanne Foster said the company delivered 15.9% organic revenue growth during the quarter, supported by record volume gains. Continuing-operations net
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ADAPTHEALTH CORP (AHCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On August 4, 2026, the Company reported second quarter results, in.
AdaptHealth guided full-year 2026 adjusted EBITDA to $680 million to $730 million on May 5, 2026, and told investors elevated labor costs would normalize. Weeks later the range was reset to approximately $490 million to $520 million.
AdaptHealth shares plunged after a deeply disappointing Q2, with a $1.07 loss and a $106 million revenue miss. AHCO is selling its Diabetes business for $235 million to Cardinal Health, exiting a low-margin segment to focus on sleep and respiratory care. New West Coast fixed-price contracts are crushing margins, with $55 million in negative impact and EBITDA guidance slashed by $160 million.